Sentence examples for biotechnology forms from inspiring English sources

The beneficiation of mineral substances through biotechnology forms the objective and basis of the present study of the pyrite bacterial leaching (bioleaching) process.

In June 2000, Icos and Texas Biotechnology formed a 50/50 partnership to research endothelin receptor antagonists for use in the areas of pulmonary hypertension and chronic heart failure.

Putting up one's guard seems to contrast intuitions reported form a Eurobarometer study on Europeans and biotechnology form 2010.

Biotechnology thus forms a catalyst for bringing together students and postdocs from across disciplines, with common interests in the biotechnology industry.

Antibodies recognizing NEMO (catalogue number SC8330; Santa Cruz Biotechnology), all forms of IKKβ (catalogue number DAM1774677; Millipore) and the HA (haemaglutinnin) tag (catalogue number 12-013-819-001; Roche) were from the sources indicated.

The report says that nine areas, all on the coasts, account for three-quarters of the biotechnology companies formed in the last decade.

A7 SCIENCE/HEALTH Report on Modified Food A biotechnology committee formed by the United States and the European Union is expected to recommend that Washington strengthen regulation of genetically modified foods and move toward mandatory labeling, according to some panel members.

A blue-ribbon biotechnology committee formed by the United States and the European Union is expected to recommend that Washington strengthen regulation of genetically modified foods and move toward mandatory labeling, according to some panel members.

Rationalising these biochemical features in relation to the chemically and physically harsh environments inhabited by these organisms and evaluating their potential (and limitations) for use in industrial biotechnology can form the basis of a range of profitable student study topics.

"The economic consequences of where these biotechnology clusters form and grow will likely be immense," says Ross DeVol, the study's principal author.

In an increasingly entrepreneurial environment, researchers and and/or institutions may own shares, options, or other interests in biotechnology companies formed for the purpose of exploiting research findings.